medigraphic.com

2012, Number 3

<< Back Next >>

Cir Cir 2012; 80 (3)

Quantitative analysis of worn and torn particles in periprosthetic tissue of hip and knee with scanning electron microscopy

Solis-Arrieta L, León-Hernández SR, Villegas-Castrejón H

Language: Spanish
References: 38
Page: 239-246
PDF size: 580.24 Kb.


ABSTRACT

Background: Arthroplasty is successful because biocompatible material is available, but its lifespan decreases due to inadequate fixation, mechanical wear and tear, or biological loss caused by osteolysis. This last is a tissue response to wear particles of the implanted material localized in the bone–prosthesis interface. We undertook this study to present the morphological analysis and characterization of the metal wear particles (MWP) in the periprosthetic tissue of patients with prosthetic loosening.
Methods: Interface tissue was studied in 63 patients with prosthetic loosening and was processed with the conventional histological technique, and tissues with wear and tear particles were subjected to chemical element determination by energydispersive X-ray analysis.
Results: Composition of the prosthesis placed in patients contained Cr-Co (30.2%), stainless steel (34.9%), Cr-Co/stainless steel (12.7%) and Ti (22.4%). Cellular response caused by wear and tear particles was classified according to three types. MWP were identified in only 19 membranes. Particle presence or absence was not significantly associated with clinical characteristics of the patient and worn and torn methacrylate or polyethylene particles. Periprosthetic membranes that showed MWP were the ones of older patients with a longer average time of graft use and those with severe necrosis.
Conclusions: No patients experienced infection at the same time with MWP probably because they were treated for prosthetic septic loosening; consequently, it is less probable that they were recruited in a cross-sectional study such as the present one.


REFERENCES

  1. Yao J, Cs-Szabó G, Jacobs JJ, Kuettner KE, Glant TT. Suppression of osteoblast function by titanium particles. J Bone Joint Surg 1997;79:107-112.

  2. Goodman S. Wear particulate and osteolysis. Orthop Clin North Am 2005;36:41-48.

  3. Colwell CW, Hozack WJ, Mesco JW, D´Antonio JA, Bierbaum BE, Capello WN, et al. Ceramic-on-ceramic total hip arthroplasty early dislocation rate. Clin Orthop Relat Res 2007;465:155-158.

  4. Maloney WJ, Smith RL. Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris. J Bone Joint Surg 1995;77:1448-1461.

  5. Shanbhag AS, Jacobs J, Black J, Galante JO, Glant TT. Effects of particles on fibroblast proliferation and bone resorption in vitro. Clin Orthop 1997;342:205-217.

  6. Choi MG, Koh HS, Kluess D, O´Connor D, Mathur A, Truskey GA, et al. Effects of titanium particle size on osteoblast functions in vitro and in vivo. Proc Natl Acad Sci USA 2005;102:4578-4583.

  7. Takei I, Takagi M, Santavirta S, Ida H, Hamasaki M, Ishii M, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints. J Biomed Mater Res 1999;45:175-183.

  8. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP. The central role of wear debris in periprosthetic osteolysis. HSS J 2006;2:102-113.

  9. Itonaga I, Sabokbar A, Murray DW, Athanasou NA. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Ann Rheum Dis 2000;59:26-31.

  10. Williams S, Tipper JL, Ingham E, Stone MH, Fisher J. In vitro analysis of the wear, wear debris and biological activity of surface-engineered coatings for use in metal-on-metal total hip replacements. Proc Inst Mech Eng H 2003;217:155-163.

  11. Campbell AP, Wang M, Amstutz CH, Goodman BS. Positive cytokine production in failed metal on metal total hip replacement. Acta Orthop Scand 2002;73:506-512.

  12. Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Köster G, et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 2005;87:28-36.

  13. Pandit H, Glyn-Jones S, McLardy-Smith P, Gundle R, Whitwell D, Gibbons CLM, et al. Pseudotumours associated with metal-on-metal hip resurfacings. J Bone Joint Surg Br 2008;90-B:847-851.

  14. Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT. The basic science of periprosthetic osteolysis. J Bone Joint Surg 2000;82-A:1478-1489.

  15. Lazarus MD, Cuckler JM, Schumacher HR, Ducheyne P, Baker DG. Comparison of the inflammatory response to particulate polymethylmethacrylate debris with and without barium sulfate. J Orthop Res 1994;12:532-541.

  16. Boybton EL, Henry M, Morton J, Waddell JP. The inflammatory response to particulate wear debris in total hip arthroplasty. Can J Surg 1995;38:507-515.

  17. Griffin BJ, Suvorova AA. Change-related problems associated with x-ray microanalysis in the variable pressure scanning electron microscope at low pressures. Microsc Microanal 2003;9:155-165.

  18. Tang X, Joy DC. Quantitative measurements of charging in a gaseous environment. Scanning 2003;25:194-200.

  19. Brown C, Williams S, Tipper JL, Fisher J, Ingham E. Characterisation of wear particles produced by metal on metal and ceramic on metal hip prostheses under standard and microseparation simulation. J Mater Sci Mater Med 2007;18:819-827.

  20. Landas S, Bonsib SM, Ellerbroek R, Fischer J. Argyria: microanalytic-morphologic correlation using paraffin-embedded tissue. Ultrastruct Pathol 1986;10:129-135.

  21. Beaulé PE, Campbell P, Mirra J, Hooper JC, Schmalzried TP. Osteolysis in a cementless, second generation metal-on-metal hip replacement. Clin Orthop 2001;386:159-165.

  22. Want A, Dorr LD. Natural history of femoral focal osteolysis with proximal ingrowth of smooth stem implant. J Arthroplasty 1996;6:718-725.

  23. Collire JP, Surprenant VA, Jensen RE, Mayor MB. Corrosion at the interface of cobalt-alloy heads on titanium-alloy stems. Clin Orthop Relat Res 1991;271:305-312.

  24. Salvati EA, Betts F, Doty SB. Particulate metal debris in cemented total hip arthroplasty. Clin Orthop Relat Res 1993;293:160-173.

  25. Moon GC, Koh SH, Kluess D, O’Connor D, Mathur A, Truskey AG, et al. Effects of titanium particle size on osteoblast functions in vitro and in vivo. Proc Natl Acad Sci USA 2005;102:4578-4583.

  26. Yavropoulou MP, Yovos JG. Osteoclastogenesis-current knowledge and future perspectives. J Musculoskelet Neuronal Interac 2008;8:204-216.

  27. Muñoz TM, Lopez FH, Fernandez GS. Advances in osteoclast biology. The osteoprotegerin RANK ligand system. Med Clin (Barc) 2004;122:75-77.

  28. Mahendra G, Pandit H, Kliskey K, Murray D, Singh HG, Athanasou N. Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties. Acta Orthop 2009;80:653-659.

  29. Gomol AH, Fitz W, Scott RD, Thornhill TS, Bellare A. Nanoparticulate fillers improve the mechanical strength of bone cement. Acta Orthop 2008;79:421-427.

  30. Wooley PH, Nasser S, Fitzgerald RH Jr. The immune response to implant materials in human. Clin Orthop 1996;326:63-70.

  31. Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000;18:849-855.

  32. Childs LM, Goater JJ, O’Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001;16:338-347.

  33. Zhang X, Morham SG, Langenbach R, Young DA, Xing L, Boyce BF, et al. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 2001;16:660-670.

  34. Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particleinduced osteolysis in a rat model. J Bone Joint Surg Am 2002;84- A:236-249.

  35. Zwolak P, Manivel JC, Jasinski P, Kirstein MN, Dudek AZ, Fisher J, et al. Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines. J Bone Joint Surg Am 2010;92:162-168.

  36. Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 2005;19:1059-1066.

  37. Takahashi N, Ozawa H. A new treatment for osteoporosis using fully human monoclonal antibody to RANKL, AMG-162. Clin Calcium 2005;15:43-48.

  38. Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1 and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004;50:277-290.




2020     |     www.medigraphic.com